Association of C4B deficiency (C4B*Q0) with erythema nodosum in leprosy.
A considerable number of studies have postulated significant associations between susceptibility to the different clinical manifestations of leprosy and the MHC. In this investigation, the association between the MHC class III complement proteins C2, BF, C4A and C4B and leprosy in a patient population of Southern Brazil was studied. A total of 109 non-related leprosy patients was investigated; 73 presented with lepromatous leprosy (LL), 46 of them had the immunopathological reaction of erythema nodosum (ENL), the remaining 36 were tuberculoid, borderline and indeterminate leprosy (TIBL) patients. The control group included 172 healthy individuals matched with the patients according to their ethnic and geographical origin. C2, BF, C4A and C4B allotypes were determined by standard technologies including Western blots for C2 and C4 variant alleles with monoclonal and polyclonal antibodies. Non-expressed ('silent') C4 alleles in hemizygously deficient individuals were estimated semiquantitatively on the basis of the C4A and C4B isotype ratio and by the MASC ('minimal chi-square') method. The results showed a significantly elevated presence of the non-expressed C4B allele (C4B*Q0) in the LL and ENL patient groups in comparison with the controls. The most significant difference was observed in the ENL group when compared with the controls. In addition, all patients who were homozygously C4B-deficient had ENL, and most of them had the BF*F1 allele. The comparison between LL patients with and without ENL also showed a statistically significant difference in the presence of C4B*Q0, indicating that C4B deficiency itself is associated with ENL. The relative risk of LL patients with the C4B*Q0 allele suffering from ENL was 5.3 compared with LL patients without C4B*Q0. Since immune complexes (IC) are considered to be the pathogenic cause of ENL, our findings indicate that C4B deficiency may play an important role in the abnormal immune response against Mycobacterium leprae and in the lack of IC clearance, leading to ENL reactions. Individuals with this allele seem to be at a higher risk of developing pathological immune reactivity in lepromatous leprosy.
de Messias
I J
IJ
Departamento de Patologia Médica, Hospital de Clinicas, Curitiba-PR, Brazil.
Santamaria
J
J
Brenden
M
M
Reis
A
A
Mauff
G
G
D000328:Adult; D000368:Aged; D000483:Alleles; D015935:Complement C4b / Q000172:deficiency* / Q000235:genetics; D011415:Complement Factor B / Q000235:genetics; D004893:Erythema Nodosum / Q000150:complications / Q000235:genetics*; D005787:Gene Frequency; D006801:Humans; D007918:Leprosy / Q000150:complications / Q000235:genetics*; D008285:Major Histocompatibility Complex; D008875:Middle Aged
D015935:Complement C4b; D011415:Complement Factor B